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Mutations in FKBP14 Cause a Variant
of Ehlers-Danlos Syndrome with Progressive
Kyphoscoliosis, Myopathy, and Hearing Loss
Matthias Baumann,1,14,* Cecilia Giunta,2,14 Birgit Krabichler,3 Franz Ru¨schendorf,4 Nicoletta Zoppi,5
Marina Colombi,5 Reginald E. Bittner,6 Susana Quijano-Roy,7 Francesco Muntoni,8 Sebahattin Cirak,8
Gudrun Schreiber,9 Yaqun Zou,10 Ying Hu,10 Norma Beatriz Romero,11 Robert Yves Carlier,12
Albert Amberger,3 Andrea Deutschmann,3 Volker Straub,13 Marianne Rohrbach,2 Beat Steinmann,2
Kevin Rosta´sy,1 Daniela Karall,1,3 Carsten G. Bo¨nnemann,10 Johannes Zschocke,3 and Christine Fauth3,*
We report on an autosomal-recessive variant of Ehlers-Danlos syndrome (EDS) characterized by severe muscle hypotonia at birth,
progressive scoliosis, joint hypermobility, hyperelastic skin, myopathy, sensorineural hearing impairment, and normal pyridinoline
excretion in urine. Clinically, the disorder shares many features with the kyphoscoliotic type of EDS (EDS VIA) and Ullrich congenital
muscular dystrophy. Linkage analysis in a large Tyrolean kindred identified a homozygous frameshift mutation in FKBP14 in two
affected individuals. Based on the cardinal clinical characteristics of the disorder, four additional individuals originating from different
European countries were identified who carried either homozygous or compound heterozygous mutations in FKBP14. FKBP14 belongs
to the family of FK506-binding peptidyl-prolyl cis-trans isomerases (PPIases). ER-resident FKBPs have been suggested to act as folding
catalysts by accelerating cis-trans isomerization of peptidyl-prolyl bonds and to act occasionally also as chaperones. We demonstrate
that FKBP14 is localized in the endoplasmic reticulum (ER) and that deficiency of FKBP14 leads to enlarged ER cisterns in dermal fibro-
blasts in vivo. Furthermore, indirect immunofluorescence of FKBP14-deficient fibroblasts indicated an altered assembly of the extracel-
lular matrix in vitro. These findings suggest that a disturbance of protein folding in the ER affecting one or more components of the
extracellular matrix might cause the generalized connective tissue involvement in this disorder. FKBP14 mutation analysis should be
considered in all individuals with apparent kyphoscoliotic type of EDS and normal urinary pyridinoline excretion, in particular in
conjunction with sensorineural hearing impairment.Introduction
The Ehlers-Danlos syndrome (EDS) comprises a clinically
and genetically heterogeneous group of heritable connec-
tive tissue disorders that predominantly affect skin, joints,
ligaments, blood vessels, and internal organs.1 Clinical
hallmarks are skin hyperelasticity, joint hypermobility,
and increased tissue fragility. The natural history and
mode of inheritance differ among the six major types.1,2
Among them, the kyphoscoliotic type of EDS (formerly
named EDS VIA [MIM 225400]) is characterized by severe
muscle hypotonia at birth, progressive kyphoscoliosis,
marked skin hyperelasticity with widened atrophic scars,
and joint hypermobility.1 Additional features are osteope-
nia without a tendency to fractures, a Marfanoid habitus,
microcornea, and occasionally rupture of the arteries and
the eye globe. The underlying defect in EDS VIA is a defi-
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nase) caused by mutations in PLOD1 (MIM 153454). This
enzyme hydroxylates lysyl residues in -Xaa-Lys-Gly- trip-
lets of collagens and other proteins with collagen-like
sequences.3 The resulting hydroxylysyl residues serve as
attachment sites for carbohydrate units and are involved
in the formation of intra- and intermolecular collagen
crosslinks, which provide mechanical stability to collagen
fibrils. A deficiency of lysyl hydroxylase results in an
abnormal urinary excretion pattern of lysyl pyridinoline
(LP) and hydroxylysyl pyridinoline (HP) crosslinks with
an increased LP/HP ratio, which is diagnostic for EDS
VIA.1,4–6
Because of severe muscle hypotonia and delayed motor
development, children with EDS VIA are initially often
suspected to have a primary neuromuscular disease.5,7
However, neuromuscular workup in the neonatal period
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Figure 1. Pedigrees of the Families
The circles indicate females, the squares males, and the triangles spontaneous abortions. Filled symbols indicate affected individuals
with proven homozygous or compound heterozygous FKBP14mutations. The index person P1 in family I (individual V-2) is indicated
by an arrow. The deceased, probably affected, member of family I is indicated as P* (individual IV-1).fatigability are common symptoms in various types of EDS
and have been explained by increased distensibility of
tendons, decreased mechanical efficiency resulting from
sparse intramuscular connective tissue, and exercise avoid-
ance because of joint instability and/or because of the weak
connective tissue surrounding the muscle spindles
embedded in the muscles.1 Recent findings8,9 suggest
that neuromuscular symptoms in EDS may in part be due
to mild to moderate myopathic and/or neuropathic
changes that have been attributed to the altered composi-
tion of the extracellular matrix in muscle and peripheral
nerve. Vice versa, primary myopathies caused by muta-
tions in extracellular matrix components, such as the
collagen type VI-related disorders Ullrich congenital
muscular dystrophy (UCMD [MIM 254090]) and Bethlem
myopathy (MIM 158810), may show substantial connec-
tive tissue involvement.10–13,36 UCMD in particular is
characterized by kyphoscoliosis, joint hypermobility, joint
contractures, and abnormal scar formation in addition to
severe muscle weakness.
A subgroup of individuals with EDS type VI has been
reported, in whom lysyl hydroxylase activity and urinary
LP/HP ratio appear to be normal.1 This condition formerly
has been classified as EDS VIB.1,14,15 In some of these
individuals, mutations in CHST14 (MIM 608429) coding
for carbohydrate (N-acetylgalactosamine 4-O) sulfotrans-
ferase 14 (D4ST1) have been reported.16–18 Various names
have been coined for disorders associated with mutations
in CHST14 such as adducted thumb-club foot syndrome
(ATCS),16 musculocontractural EDS (MCEDS [MIM
601776]),17 or EDS Kosho Type (EDSKT).19 Recently,
Shimizu et al.19 suggested that ATCS, MCEDS, and EDSKT202 The American Journal of Human Genetics 90, 201–216, Februaryare a single clinical entity with variable expression and
proposed the unifying name ‘‘D4ST1-deficient EDS’’ for
the clinical spectrum of manifestations.
Here we report an autosomal-recessive variant of EDS
with kyphoscoliosis and normal urinary LP/HP ratio,
which we identified in six affected individuals from five
unrelated families originating from different European
countries. This disorder shares many clinical features
with EDS VIA but is also characterized by sensorineural
hearing loss. Affected individuals show clear signs of a
myopathy as demonstrated by clinical, electrophysiolog-
ical, imaging, and muscle biopsy findings. We identified
causative mutations in FKBP14, which codes for a member
of the FK506-binding family of peptidyl-prolyl cis-trans
isomerases (PPIases), in all individuals with this disorder.
Subjects and Methods
At 14 years of age, the index person P1 (individual V-2 in family I,
Figure 1) was referred to the Department of Paediatrics IV at
Innsbruck Medical University (MB) for the evaluation of severe
kyphoscoliosis, joint hypermobility, and muscle weakness. He
was initially suspected to have EDS VIA, but the urinary LP/HP
ratio was within the normal range. Pedigree analysis revealed
that the index person’s father had a cousin (P2, individual IV-2
in family I, Figure 1) who was affected by the same disorder. The
parents of both affected family members were not knowingly
consanguineous but originated from neighboring small villages
in Tyrol (Austria), and therefore autosomal-recessive inheritance
was assumed and linkage analysis was performed in order to
identify the candidate gene.
Based on clinical characteristics, four additional individuals
affected by the same disorder were identified. Their families10, 2012
originated from Italy, Turkey, France, and Germany, respectively.
The pedigrees of the families involved in the study are depicted
in Figure 1. Salient clinical and neuromuscular findings are
summarized in Tables 1 and 2 and Figures 2 and 3.
All individuals participating in the study gave their informed
consent. All procedures followed were in accordance with the
institutional (Medical University Innsbruck) and national ethical
standards of diagnostic and research investigations.P1
P1 (individual V-2 in family I, Figure 1) was born spontaneously
at term after an uneventful pregnancy by vaginal delivery
with cephalic presentation. Birth measurements were within the
normal range (weight 50th centile, length 10th–25th centile). He
presented at birth with severe muscle hypotonia, paucity of anti-
gravity movements, poor sucking, hypermobile joints, and
slightly bluish sclerae. Infantile spinal muscular atrophy was
excluded. At the age of 2 months, first signs of a spinal deformity
developed. In the subsequent months muscle weakness and hypo-
tonia improved. Motor development was delayed, but speech and
mental development were normal. He was able to sit without
support at 13 months and walked without assistance at 2.5 years.
At the age of 2 years, a unilateral inguinal hernia required surgical
correction. A chronic subdural hygroma causing increased intra-
cranial pressure was treated with a subdural-peritoneal shunt at
the age of 3 years. Bilateral sensorineural hearing impairment
affecting predominantly high frequencies (70–80 dB HL at 4–
6 kHz)was diagnosed at 6 years and hewas providedwith a hearing
aid. At the age of 9 years, a large bladder diverticulum was surgi-
cally removed. Scoliosis progressed despite management with
a thoracolumbar orthosis and led to a restrictive ventilation
disorder (FVC 34%). Echocardiography and thoraco-abdominal
CT scan at the age of 13 years showed no signs of cardiomyopathy
and no dilatation of the aorta or other large vessels.
At the current age of 16 years, he has severe kyphoscoliosis
(Figure 2A) andmarked hypermobility of the large and small joints
(Beighton score 6/9), but no contractures. He has a characteristic
handshake with the hands feeling ‘‘like a bag of little bones’’
because the musculoskeletal structure of the hands seems to
collapse on pressure. The skin is thin, soft, and hyperelastic
(Figure 2L) with follicular hyperkeratosis but no signs of increased
fragility or atrophic scars. Over the left deltoid area, where a skin
biopsy was taken, two small keloids are visible. There is no skin
wrinkling of the palms. He has myopia of 6–7 diopters, and the
cornea diameter is within the normal range. Arm span and lower
length are within the normal range, but the standing height is
reduced because of severe kyphoscoliosis (10 cm below the third
centile). He is able to walk up to 1 km and to climb stairs without
using the handrail. Muscle strength is between 3 (neck flexion)
and 4 on the MRC scale.P2
P2 (individual IV-2 in family I; Figure 1) is the first cousin of the
father of P1. She was born at term after an uneventful pregnancy,
but the mother reported feeble fetal movements. Birth measure-
ments were within the normal range (weight 10th–25th centile,
length 50th centile). At birth she presented as a floppy infant
with severe muscle hypotonia and weakness. Gross motor mile-
stones were delayed. She was able to walk without help at the
age of 3 years. At the age of 2 years, a scoliosis was noted, which
slowly progressed and required a first surgical correction at theThe Americaage of 11 years. Moderate bilateral sensorineural hearing impair-
ment affecting predominantly high frequencies was diagnosed at
the age of 6 years and she was supplied with a hearing aid. She
reported that hearing impairment was not progressive over the
years.
In her 40s, she developed progressive weakness of the lower
limbs. At the current age of 48 years, she has difficulty climbing
stairs and has to rest after a walking distance of 500 m. Toe and
heel walking are not possible. Muscle strength is between 3
(hip abduction) and 4 on the MRC scale. Clinical examination
shows a moderate degree of muscular atrophy in the legs and
intrinsic hand muscles (Figure 2J). She has no sensory deficit. In
comparison to the other affected individuals of the present study
who are much younger, joint hypermobility is less pronounced,
but there is marked instability in the knees and the Beighton score
is still 6/9. Her skin is soft and hyperelastic and bruises easily.
There is no abnormal scarring. She has myopia of 6 diopters and
the cornea diameter is normal. Her weight is at the third centile
and her height 3 cm below the third centile.
An older sister of P2 (indicated as P* [individual IV-1 in family I]
in Figure 1 and Tables 1 and 2) was probably also affected by the
same disorder, but clinical information was limited and DNA
was not available for molecular confirmation. She was born at
35 weeks of gestation by breech delivery (weight 50th–75th centile)
and presented at birth with hypotonia, feeding problems, and
a weak cry. Motor milestones were delayed. She was able to walk
independently at the age of 2.5 years. At the age of 7.5 years,
muscle hypotonia, shoulder girdle weakness, flat feet, and mild
but progressive kyphoscoliosis as well as follicular hyperkeratosis
were reported. Subsequently, hypotonia and muscle weakness
improved over time, and there was no recorded muscle weakness
at the age of 10–12 years. There is no information available on
the hearing status of P*. She died unexpectedly of aortic rupture
at the age of 12 years.
P3
P3 (individual II-4 in family II, Figure 1) is the youngest of four
children of nonconsanguineous parents originating from South
Tyrol (Northern Italy). The mother reported feeble fetal move-
ments during pregnancy. The child was born after premature
rupture of membranes at 36 weeksþ 5 days of gestation by vaginal
breech delivery. Birth weight and length were within the normal
range (weight 10th–25th centile, length 10th centile). After birth
she was noted to have severe hypotonia with few spontaneous
movements and distally pronounced joint hypermobility. Her
cry was weak and she had feeding problems. Subsequently weak-
ness and hypotonia improved and she achieved head control by
the age of 1 year. Unaided sitting was possible at the age of 2 years
and she was able to walk independently at the age of 4 years. Since
the age of 4 months she developed progressive kyphoscoliosis and
underwent spinal surgery at the age of 4 years. At the same time
bilateral sensorineural hearing impairment affecting predomi-
nantly high frequencies was diagnosed (present status: 10–25 dB
HL < 4 kHz and 45–55 dB HL at 6 kHz). Her mental development
has been normal.
At the present age of 11 years, her gait is characterized bymarked
instability in both knees (Figure 2C) and there is also pronounced
joint hypermobility of the small joints (Figure 2D) (Beighton
score 8/9). After walking more than 200 m, she is exhausted and
needs a wheelchair. Muscle strength is between 3 (neck flexion)
and 4þ on the MRC scale. Her skin is soft and hyperelastic
(Figure 2K) with follicular hyperkeratosis (Figure 2M) but withoutn Journal of Human Genetics 90, 201–216, February 10, 2012 203
Table 1. Salient Clinical Findings
P1 P2 P* P3 P4 P5 P6
Current age/gender 16 y/M 48 y/F 12 y/Fa 11 y/F 16 y/F 11 y/M 3 y/F
Origin Austria Austria Austria Italy France Turkey Germany
Skin
hyperelastic þ (þ) nr þ – þ þ
soft þ þ nr þ þ þ þ
plantar softness þ – nr þ þ þ þ
follicular
hyperkeratosis
þ – þ þ þ – þ
easy bruising – þ nr (þ) – þ –
hypertrophic scars (þ) – nr – – – –
atrophic scars – – nr – – – –
Joints
hypermobility
of large joints
þ þ þ þ þþ þþ þ
hypermobility
of small joints
þþ þ þ þþ þþ þþ þþ
Beighton score 6/9 6/9 nr 8/9 6/9 9/9 9/9
recurrent dislocations – – – – – þþ –
joint contractures – – – – – – –
Skeletal
progressive
kyphoscoliosis
þþ þþ (11 y op) þ þþ (4 y op) þþ (12 y op) kyphosis scoliosis
flat feet þ þ þ þ þ, club
foot left
þ þ, club
foot left
fractures – – – – – (þ) –
Neuromuscular
muscle hypotonia
at birth
þþ þþ þþ þþ þþ þþ þþ
poor head control
in infancy
þ þ þ þ þ þ þ
weakness improving
in infancy
þ þ þ þ þ þ þ
delayed motor
development
þ þ þ þþ þ þþ þþ
walking
independently
2.5 y 2.5 y 2.5 y 4 y 2 y 4 y 3 y
supported
muscular atrophy þ þ (þ) (þ) þ (þ) (þ)
current MRC
muscle score
3–4 3–4 nr 4 4 3–4 3–4
Cardiovascular
cardiomyopathy – nr nr – – – –
valvular abnormalities – nr nr – tricusp. insuf. I mitral and
tricusp. insuf. I
–
vascular abnormalities – – aortic rupture – – – –
Eyes and Ears
bluish sclerae þ in infancy – nr – – – –
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Table 1. Continued
P1 P2 P* P3 P4 P5 P6
Current age/gender 16 y/M 48 y/F 12 y/Fa 11 y/F 16 y/F 11 y/M 3 y/F
Origin Austria Austria Austria Italy France Turkey Germany
myopia þ þ þ – þ – –
microcornea – – nr – – – –
hearing impairment sensorineural sensorineural nr sensorineural conductive sensorineural sensorineural
Miscellaneous
herniae inguinal umbilical – umbilical – umbilical –
bladder diverticulum þ nr nr nr nr þ nr
cleft soft palate – – – – – þ þ
retrogenia in infancy – – – – – þ þ
subdural hygroma microcephaly,
learning difficulties
Abbreviations: P*, probably affected person; y, years; F, female; M, male; (þ), mildly present; þ, present; þþ, explicitly present; –, absent; nr, not recorded; op,
operation; MRC, Medical Research Council scale for muscle strength.
a Patient P* died at the age of 12 years.abnormal scarring. Repeated echocardiographic examinations
showed no signs of cardiomyopathy or dilatation of the thoracic
aorta. She has no myopia and her cornea diameter is within the
normal range. Currently, her weight is between the third and
tenth centile and her length is 5 cm below the third centile.
P4
P4 (individual II-4 in family III, Figure 1) is the second child of
nonconsanguineous French parents. She presented at birth as
a floppy infant with generalized hypotonia and muscle weakness,
joint hypermobility, and a left sided club foot. Motor milestones
were delayed. She achieved head control at 7 months, was able
to sit at the age of 12 months, and walked unaided at the age of
2 years. Early-onset kyphoscoliosis was treated with a brace from
the age of 18 months. There was a strong kyphotic component
associated with pathological rotation resulting in three curves of
the spine. Treatment by serial casts at night stabilized the spinal
deformity until the end of growth when she underwent spinal
fusion operation. Muscle weakness improved over time; at the
current age of 16 years, she can get up from the floor without
help, walk up to 1 km, and can climb 20–30 steps of stairs without
stopping. The skin on arms and legs shows follicular hyperkera-
tosis and there are thick and papulous lesions of the skin in the
pressure areas of elbows and knees. She has no atrophic scars
and doesn’t report easy bruising. Her joints are hypermobile
(Beighton score 6/9). At the age of 16 years, conductive hearing
impairment was diagnosed. Cardiac echography showed a mildly
insufficient tricuspid valve. She has myopia of 5 diopters. Her
present weight is between the 10th and 25th centile and length is
1 cm below the 3rd centile.
P5
P5 (individual IV-4 in family IV, Figure 1) is the third child of
first-degree cousins of Turkish origin. The mother reported
reduced fetal movements. She went into spontaneous labor at
36 weeks and a premature rupture of membranes was noted.
The baby was in breech presentation and was delivered by
emergency caesarean section (weight 90th centile). He was aThe Americafloppy infant and required nasogastric tube feeding for 9 months
because of a cleft of the soft palate and a weak suck. He had
micrognathia that later on spontaneously resolved. Hypotonia
(Figure 2I), feeding, and motor function slowly improved with
age. Sensorineural hearing impairment affecting predominantly
high frequencies was diagnosed at the age of 2 years and treated
with a hearing aid (present status: 35–55 dB HL % 4 kHz and
90–95 dB HL R 5 kHz). At the present age of 11 years, he has
generalized muscle weakness with muscle strength between 3
(axial and neck muscles) and 4 on the MRC scale. He has difficul-
ties with getting up from the floor (Gowers time of 9 s) and with
climbing stairs and complains about myalgia and joint pain after
walking for more than 15 min. A nonprogressive kyphosis was
diagnosed after the first year of life, but so far he has not devel-
oped a scoliosis. Hypermobility of the joints (Figure 2E) (Beighton
score 9/9) has led to recurrent dislocations of shoulder, elbow,
knee, and hip joints. Additionally, dislocations of small finger
joints cause significant difficulties with fine motor tasks such as
cutting food and dressing. Wound healing is delayed, but he
has no atrophic scars or keloids. He has no myopia. In contrast
to the other affected individuals of the present study, he has
moderate intellectual disability and uses Makaton language to
combine spoken words with gestures, signs, and symbols. A brain
MRI at the age of 9 years showed mild white matter atrophy. At
the age of 11 years during diagnostic work-up for incontinence,
a large bladder diverticulum was diagnosed by ultrasound. His
present weight is at the 90th centile and length is between the
25th and 50th centile.
P6
P6 (individual II-2 in family V, Figure 1) is the first child of a non-
consanguineous German couple. She was born in the 37th week of
gestation after a pregnancy complicated by polyhydramnios. Birth
measurements were within the normal range (weight 25th centile,
length 10th–25th centile). After birth, she presented as a floppy
infant (Figure 2H) with a left sided clubfoot, retrogenia, and
a median cleft of the soft palate. She had feeding problems and
showed repeatedly inadequate oxygen saturation levels. She wasn Journal of Human Genetics 90, 201–216, February 10, 2012 205
Table 2. Neuromuscular Investigations
P1 P2 P* P3 P4 P5 P6
Current age 16 y 48 y 12 ya 11 y 16 y 11 y 3 y
Laboratory
Creatine kinaseb normal slightly elevated
(31.2)
normal normal normal slightly elevated
(31.2)
slightly elevated
(31.3)
Urinary
crosslinks
(LP/HP ratio)
normal normal normal normal normal normal
Nerve Conduction
Result normal normal normal normal normal
Electromyography
Age, result 3 m, normal 6 y, normal 6 y, myopathic 4 m, normal 1 y, myopathic
Age, result 15 y, myopathic 30 y, myopathic 2 y, normal
Muscle Biopsy
Age, site, result 2 y, quadriceps,
irregular oxidative
enzymes; EM:
focal myofibrillar
rearrangements
(Figure 3E)
2 y, quadriceps,
marked fiber
atrophy
6 y, nr,
myopathic
4 m, quadriceps,
mildly myopathic
2 y, quadriceps,
mildly myopathic
1 y, quadriceps,
myopathic
1 y, quadriceps, mildly
myopathic with increased
variation of fiber diameter
(Figures 3A and 3B)
Age, site, result 4 y, nr, marked atrophy,
proliferation of
fatty tissue
4 y, paraspinal,
areas with fiber atrophy,
slightly increased intrafusal fat
6 y, nr, myopathic
Age, site, result 7 y, anterior tibial,
myopathic,
proliferation of
fatty tissue
6 y, paraspinal, areas with
central activity defects of
oxidative enzymes, (Figure 3C);
EM: focal myofibrillar
rearrangements (Figure 3D)
12 y, dorsal, myopathic with
increased variation of fiber
diameter; EM: bifurcation of
sarcomeres, small zones of
Z-band streaming and some
disorganized myofibrils (Figure 3F)
Age, site, result 30 y, paraspinal,
mildly myopathic,
atrophic fibers
Muscle MRI
Age, result 15 y, normal in
lower limbs
12 y, marked signal abnormalities
in rectus femoris, vastus lateralis
and soleus; mild involvement of
hip flexors, neck extensors,
and shoulder girdle (Figure 3A)
11 y, marked signal
abnormalities in rectus
femoris, vastus lateralis,
medial head of gastrocnemius,
soleus, and paraspinal muscles
The following symbols and abbreviations are used: P*, probably affected person; m, months; y, years; EM, electron microscopy.
a Patient P* died at the age of 12 years.
b x-fold upper limit.
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Figure 2. Clinical Phenotype
Clinical findings in individuals with FKBP14-deficient EDS.
(A and B) Severe kyphoscoliosis in P1 (age 15 years) (A) and lumbar scoliosis in P6 (3 years) (B).
(C–G) Genu recurvatum in P3 (C) and distally pronounced joint hypermobility in P3 (D, 10 years), P5 (E, 3 years), and P6 (F and G, 3
years).
(H and I) Muscle hypotonia and weakness in P6 (H, 3 months) and P5 (I, 1.5 years).
(J) Moderate atrophy of intrinsic hand muscles in P2 (47 years).
(K and L) Hyperelastic skin of the forearm of P3 (K, 10 years) and the neck region of P1 (L, 16 years).
(M) Follicular hyperkeratosis in the pretibial region of P3 (10 years).discharged with oxygen support for acute desaturations and
a feeding tube. Clubfoot and cleft palate were repaired surgically.
At the age of 18 months, first signs of lumbar scoliosis were noted.
Hypotonia and muscle weakness gradually improved. However,
gross motor milestones continued to be delayed. At the present
age of 3 years, she is unable to walk without support and has
hypermobile joints (Figures 2F and 2G) (Beighton score 9/9) as
well as a lumbar scoliosis (Figure 2B). Moderate sensorineural
hearing impairment was diagnosed at the age of 3 years and
treated with a hearing aid. The cornea diameter is normal and
she has no myopia. Current weight and height measurements
are within the normal range (weight between the 3rd and 10th cen-
tile, length between the 25th and 50th centile).
Radiological Findings
Original radiographic images were available for individuals P1 and
P3 and radiology reports for P2, P*, and P5. Because all affected
individuals have kyphosis and/or scoliosis, the most comprehen-
sive radiological information was available for the vertebral spine.
In addition, in individuals P1 and P3, X-ray examinations of the
pelvis were performed and information on X-rays of the left
hand were available for P1, P2, and P*.
Radiographs showed no signs of skeletal dysplasia. Judged by
radiology, mild to moderate osteopenia was present in all subjects
studied, but there was no increased bone fragility. Bone age corre-
sponded to the chronological age. In individual P1, osteopenia isThe Americaevidenced by translucent vertebral bodies in comparison to the
cortical outline, deformed vertebral bodies, and trabecular promi-
nence in femoral necks (Figure S2 available online).
Neuromuscular Findings
Results of neuromuscular investigations are summarized in
Table 2.
In all affected individuals, serum creatine kinase levels were
normal or only slightly elevated (range 60–300 IU/l). Nerve
conduction studies were normal. Electromyography showed
a myopathic pattern in adolescence and adulthood but results
obtained in infancy were mostly reported as normal.
In all individuals except P*, the first muscle biopsy was per-
formed before the age of 2.5 years. These biopsies were taken
from the quadriceps muscle. In three affected individuals,
repeated biopsies were performed, preferentially during spinal
surgery with biopsies from dorsal or paraspinal muscles. Speci-
mens for light microscopy were immediately frozen and processed
via standard histological and histochemical techniques. In three
affected individuals (P1, P3, and P4), muscle electron microscopy
was performed by standard procedures.
Histopathological features ranged from nonspecific mild
myopathic changes with increased variation in muscle fiber
diameter (Figures 3A and 3B) to more pronounced changes with
profound fiber atrophy and proliferation of fatty tissue. Immuno-
fluorescence labeling of type VI collagen in muscle cryosectionsn Journal of Human Genetics 90, 201–216, February 10, 2012 207
Figure 3. Muscle MRI, Histomorphology, and
Ultrastructure of Muscle and Skin
(A and B) Histomorphology of a muscle biopsy
taken from the quadriceps muscle of P6 at
the age of 1 year showing mild changes with
increased variation in muscle fiber diameter:
Gomori trichrome (A) and NADH-TR stain (B).
(C and D) Histochemistry (NADH-TR) of a muscle
biopsy from the paraspinal muscle of P3 at the
age of 6 years shows areas with central activity
defects of oxidative enzymes (C), corresponding
to focal rearrangements of myofibrils in electron
microscopy (D).
(E and F) Transmission electron microscopy of
muscle (longitudinal sections) in P1 and P4.
(E) Electron microscopy in P1 shows focal rear-
rangements of myofibrils with irregular Z lines
(arrow) (quadriceps muscle, at the age of 2 years).
(F) Electron microscopy in P4 shows bifurcation
of sarcomeres, small zones of Z-band streaming
(arrow), and some disorganizedmyofibrils (dorsal
muscle, at the age of 12 years).
(G) Transverse T1-weighted muscle MRI cross
sections of the right thigh and lower leg in P4
at the age of 12 years show abnormal signals in
the rectus femoris (RF), vastus lateralis (VL), and
soleus (So) muscles indicating fatty degeneration
of muscle tissue.
(H and I) Two images of transmission electron
microscopy of a skin biopsy of P1 show abnor-
mally enlarged ER cisterns filled with a flocculent
material; collagen fibrils are normal in shape and
diameter.
Scale bars represent 20 mm in light microscopy
and 2 mm in electron microscopy.was performed in P5 and showed normal results. Muscle histo-
chemical studies in P1 and P3 showed irregularities of the
oxidative enzymes, including areas with central activity defects in
paraspinal muscle from P3 (Figure 3C); the latter changes corre-
sponded to focal rearrangements of myofibrils in electron micros-
copy (Figure 3D). Likewise, electron microscopy studies of a
quadriceps biopsy taken from P1 at the age of 2 years showed focal
rearrangements of myofibrils with irregular Z lines (Figure 3E), and
electronmicroscopy of a biopsy from the dorsal muscle of P4 taken
at the age of 12 years showedbifurcationof sarcomeres, small zones
of Z-band streaming, and some disorganizedmyofibrils (Figure 3F).
Whole-body muscle MRI performed in P4 at the age of 12 years
showed fatty replacement of muscle tissue on T1 weighted images
in the rectus femoris, vastus lateralis, and soleus muscles
(Figure 3G). There was also mild involvement of neck extensor,
shoulder girdle, and hip flexor muscles (not shown).
The muscle MRI of P5 at the age of 11 years showed a similar
pattern with fatty infiltration in the paraspinal and leg muscles.
In the thighs, the rectus femoris and vastus lateralis were predom-
inantly affected with relative sparing of the adductor compart-
ment. In the calves, the changes were most pronounced in the
medial head of the gastrocnemius muscle and in the soleus muscle
(not shown). Muscle MRI of the lower limbs in P1 at the age of
15 years was normal.Biochemical and Ultrastructural Analyses
Total urinary pyridinoline crosslinks, lysyl pyridinoline (LP), and
hydroxylysyl pyridinoline (HP) were measured in all affected
individuals by HPLC as described.5,6 Dermal fibroblast cultures
were established from skin biopsies of P1, P3, and P6 by routine208 The American Journal of Human Genetics 90, 201–216, Februaryprocedures. For the semiquantitative analysis of collagen types I,
III, and V, fibroblasts of P1 and P3 weremaintained under standard
conditions, and radiolabeled collagen samples were prepared
by digestion with pepsin, precipitated by ethanol, separated on
a 5% SDS-polyacrylamide gel (SDS-PAGE), and visualized by
fluorography.20
A skin biopsy of individual P1 taken from the deltoid area was
fixed in 3% glutaraldehyde solution for ultrastructural analysis
as described.21Molecular Genetic Studies
Genomic DNA was isolated from peripheral blood leukocytes via
standard procedures (BioRobot M48, QIAGEN). A genome-wide
scan was performed for 23 subjects (family I in Figure 1) with the
HumanCytoSNP-12v2 BeadChip (Illumina, CA) according to the
manufacturer’s instructions. These arrays contain 294,747 single-
nucleotide polymorphism (SNP) markers with a mean intermarker
distance of about 10 kb. Raw SNP call data were processed with the
Genotyping Analysis Module of GenomeStudio 1.6.3 (Illumina).
Parametric linkage analysiswas performedwith Simwalk2.22 A trait
locus mutant allele frequency of 0.0001 was assumed under an
autosomal-recessive mode of inheritance with complete pene-
trance. Marker allele frequencies were determined out of 279 indi-
viduals of European descent from our Illumina project. Data
management and cleaning was done with ALOHOMORA,23
GRR,24 PedCheck,25 Merlin,26 and Mega2.27 After erasement of
Mendelian errors, non-Mendelian errors, and unlikely genotypes,
residual markers were selected for a minimal spacing between
neighboring markers of 100,000 bp and a minimal minor allele
frequency of 0.3. Linkage analysis was calculated with 19,76610, 2012
markers in marker sets of 100 SNPs. For haplotype analysis and au-
tozygositymapping in the candidate regions, we used the program
Merlin and split the pedigree into two parts, each with a loop and
cousin marriage of third order. For those regions we used all
markers after normal quality control without minimal spacing.
For mutation analysis of the candidate gene FKBP14 (RefSeq
accession number NM_017946.2 [mRNA], NP_060416.1 [pro-
tein]), the coding region and the flanking intron-exon boundaries
were PCR amplified with primers based on the Ensembl genome
browser entry for the genomic DNA (ENSG00000106080) (for
primer sequences, please see Supplemental Data). PCR products
were purified with ExoSAP-IT (USB Corporation, Cleveland, OH)
followed by bidirectional sequencing with M13 forward and
reverse primers with BigDye Terminator v3.1 Cycle Sequencing
Kit on a fluorescent DNA sequencer (3730s DNA Analyzer, Applied
Biosystems).
Relatives as well as 200 European control samples were tested
for the detected mutations either by bidirectional sequencing
(for the single base pair insertion c.362dup in exon 3) or by PCR
amplification and DNA gel electrophoresis (for the 19 base pair
deletion c.42_60del in exon 1, QIAXCEL system, QIAGEN) (for
primer sequences, please see Supplemental Data).
Gene expression of FKBP14 was analyzed by quantitative RT-
PCR (qRT-PCR) in fibroblasts from individuals P1 and P3 and
two healthy controls. Total RNA was extracted with RNeasy Mini
kit (QIAGEN, Hilden, Germany) according to the manufacturer’s
protocol. Reverse transcription was performed with 1 mg total
RNA and the RevertAid Premium First Strand cDNA Synthesis kit
(Fermentas, St. Leon-Rot, Germany). 1/10 volume of this reaction
was used to carry out a real-time quantitative PCR amplification
via Maxima SYBR Green/ROX qPCR Master Mix (Fermentas) in
an ABI Prism 7000 sequence detection system (Applied Bio-
systems). PCR reaction was carried out by an initial denaturation
step 95C for 10 min followed by 40 cycles of 15 s denaturation
at 95C and 1 min annealing/extension at 60C and a dissociation
analysis (60C–95C). The CT values were calculated with
sequence-detection system (SDS) software V1.2 (Applied Bio-
systems) and an automatic setting of base line. The amplification
plots and CT values were exported from the exponential phase of
PCR directly into a Microsoft Excel worksheet for further analysis.
Quantification of relative gene expression was done by com-
parative DDCt method with HPRT1 (RefSeq accession number
NM_000194.2 [mRNA]) as reference gene (for primer sequences,
please see Supplemental Data).28Western Blot and Indirect Immunofluorescence
Microscopy of FKBP14 and Extracellular Matrix
Proteins
For western blot analysis, a FKBP14 mouse polyclonal antibody
(Abnova) and a mouse anti-a-tubulin monoclonal antibody
(1:1000; sc-8035, Santa Cruz Biotechnology, Santa Cruz, CA)
were used. Proteins were resolved by electrophoresis in a 12%
polyacrylamide gel under denaturing conditions and blotted ac-
cording to a standard protocol. As secondary antibodies, goat
anti-mouse IgG conjugated to horseradish peroxidase were used.
The blot was developed with ECL western blotting detection
reagents (GE Healthcare, Little Chalfont, Buckinghamshire, UK)
according to the manufacturer’s instructions.
For immunofluorescence (IF) staining of FKBP14 in fibroblasts of
affected individuals and control persons, cells grown in a 8-well
chamber slide for 16–20 hr were fixed with 4% paraformaldehydeThe America(PFA), blocked in 10% fetal bovine serum (FBS)/0.1% Triton
X-100/phosphate-buffered saline (PBS), incubated for 1.5 hr with
FKBP14 rabbit polyclonal antibody 1:200 (ProteinTech 15884-1-
AP) and HSP47 mouse monoclonal antibody 1:1000 (Stressgen
SPA-470), and subsequently exposed to goat anti-rabbit Alexa Fluor
488 1:500 (Invitrogen A11034) and goat anti-mouse Alexa Fluor
568 1:500 (Invitrogen A11031) for 1 hr. Nuclear counterstaining
was done with 40,6-diamidino-2-phenylindole (DAPI). Images
were captured by a Zeiss LSM 510 Confocal imaging system.
For indirect IF microscopy of extracellular matrix proteins,
fibroblast cultures of individuals P1 and P3 and two healthy
controls were grown in Earle’s Modified Eagle Medium (MEM)
(Invitrogen-Life Technology, Carlsbad, CA) supplemented with
10% FBS (Invitrogen-Life Technology), 100 IU/ml penicillin, and
100 mg/ml streptomycin (complete MEM) without addition of
ascorbic acid at 37C in a 5% CO2 atmosphere.
Rabbit anti-fibronectin polyclonal antibody, mouse anti-tenas-
cin monoclonal antibody (clone BC-24), recognizing all the tenas-
cins, mouse anti-a5b1 (clone JBS5) and anti-a2b1 (clone BHA.2)
integrins and mouse anti-collagen VI (clone 3C4) monoclonal
antibodies, and goat anti-collagen type I, anti-collagen type III,
and anti-collagen type V antibodies were from Millipore Chemi-
con Int. Inc. (Billerica, MA). FITC- and TRITC-conjugated goat
anti-rabbit and anti-mouse and rabbit anti-goat secondary anti-
bodies were from Calbiochem-Novabiochem INTL. The anti-
thrombospondin monoclonal antibody was from NeoMarkers,
Lab Vision (Fremont, CA).
To analyze the organization of fibronectin, collagen types I, III,
and V, and tenascins, 1.0 3 105 cells were grown for 48 hr on
glass coverslips in complete MEM, fixed in methanol, and incu-
bated with the specific antibodies, as previously reported.29,30
To analyze the organization of collagen type VI, fibroblasts
were cultured for 7 days in the presence of 0.25 mM ascorbic
acid, fixed in methanol, and immunoreacted with anti-collagen
type VI monoclonal antibody.
The organization of a5b1 and a2b1 integrins was analyzed on
1.0 3 105 cells grown for 48 hr in complete MEM, fixed in 3%
paraformaldehyde (PFA) and 60 mM sucrose, and permeabilized
in 0.5% Triton X-100. Cells were incubated for 1 hr at room
temperature with 1 mg/ml anti-a5b1 and anti-a2b1 integrins
monoclonal antibodies. In order to analyze the organization of
thrombospondin, the cells were fixed for 10 min in 3% PFA and
incubated with 1 mg/ml of the specific monoclonal antibody.
In all IF experiments, the cells were subsequently incubated
for 45 min with 10 mg/ml FITC- or TRITC-conjugated anti-rabbit,
anti-goat, or anti-mouse IgG. The IF signals were acquired by a
CCD black/white TV camera (SensiCam-PCO Computer Optics
GmbH, Germany) mounted on a Zeiss fluorescence-Axiovert
microscope, and digitalized by Image Pro Plus program (Media
Cybernetics, Silver Spring, MD).Results
Molecular Analysis
Total urinary LP/HP ratios were normal in all affected
individuals, thereby excluding EDS VIA.
Because no diagnosis could be established based on
clinical findings, linkage analysis was performed in family
I. Linkage analysis revealed three candidate loci on chro-
mosomes 7, 11, and 16 with a maximum LOD scoren Journal of Human Genetics 90, 201–216, February 10, 2012 209
Figure 4. Subcellular Localization of FKBP14, Western Blot Analysis, and Nonsense-Mediated Decay
(A) Immunoblot shows absence of FKBP14 in skin fibroblasts of P1 and P3 in comparison to controls.
(B) Confocal immunofluorescence microscopy shows colocalization of FKBP14 (red) and HSP47 (green) in control fibroblasts. In fibro-
blasts from P1 and P3, FKBP14 is not detectable. Nuclei are counterstained by DAPI. Scale bar represents 10 mm.
(C) qRT-PCR analysis of FKBP14 in P1, P3, and two control individuals. Relative expression was determined by the DDCt method with
HPRT1 as reference gene. Expression of FKBP14 was strongly reduced in patient fibroblasts, indicating nonsense-mediated decay.of 2.657 (data not shown) spanning 9,106,202 bp (be-
tween rs7781656 and rs2709800), 4,997,061 bp (between
rs11607726 and rs12786091), and 3,963,702 bp (between
rs13332406 and rs657181), respectively. The linkage
regions were recalculated with Merlin performing haplo-
type analysis and autozygosity mapping without marker
selection (chr7, 1083 markers; chr11, 617 markers; chr16,
696 markers) to further narrow the linkage regions. Haplo-
type analysis showed that the affected individuals were
homozygous identical by descent (IBD) for only two
linkage regions, 7p15.1 and 16q12.2. The size of the homo-
zygous linkage interval on chromosome 7 was narrowed to
670,554 bp (flanking markers rs767430–rs2709800) and
the region on chromosome 16 to 724,063 bp (flanking
markers rs2110835–rs1486733).Within the linkage regions
on chromosomes 7 and 16, there were in total 13 genes/
open reading frames: WIPF3 (MIM 612432), SCRN1,
FKBP14, PLEKHA8 (MIM 608639), C7orf41, ZNRF2 (MIM
612061), MIRN550-1, DKFZp586I1420, NOD1 (MIM
605980), LOC643911, LOC388279, IRX5 (MIM 606195),
and LOC100132339 (annotation according to Build 36.3,
which was the genome assembly available at the time of
investigation). Considering that the disease affects connec-
tive tissue and muscle and based on the putative function
and the expression profile, one major candidate gene
emerged, FKBP14 (FK506 binding protein 14, 22 kDa,
NCBI Gene ID: 55033), which maps to 7p15.1. FKBP14
belongs to the FK506-binding protein (FKBP) class of im-
munophilins, which have been implicated in catalyzing
cis-trans-isomerization of peptidyl-prolyl peptide bonds
and are supposed to accelerate protein folding.31
FKBP14 sequence analysis in the affected members of
family I revealed a homozygous insertion of one cytosine210 The American Journal of Human Genetics 90, 201–216, Februaryresidue within a 5C-nucleotide repeat in exon 3
(c.362dup), which produces a translational frameshift
and a premature stop codon (p.Glu122Argfs*7). The tran-
script was predicted to be targeted by nonsense-mediated
RNA decay.
We subsequently carried out molecular genetic studies
in four unrelated individuals presenting with a similar
clinical phenotype (families II–V, Figure 1). Individuals
P3, P4, and P5 were found to be homozygous for the
c.362dup mutation, whereas P6 was compound heterozy-
gous for c.362dup (on the maternal allele) and a 19 base
pair deletion c.42_60del in exon 1 (on the paternal allele),
which leads to a premature stop codon (p.Thr15*). Neither
mutation is registered in the available SNP databases, nor
was it found in a panel of 200 control persons of European
descent, indicating that they are not common polymor-
phisms. The c.362dup mutation was linked to the same
haplotype in all individuals.
FKBP14 Mutation Results In Vitro in Deficiency
of FKBP14
In order to determine the subcellular localization of
FKBP14 in control cells and the effect of the mutations
on the protein level, fibroblasts of affected individuals
and healthy controls were analyzed by immunocytochem-
istry and confocal microscopy as well as by western blot
analysis. The results of confocal microscopy are shown in
Figure 4B. In control fibroblasts, FKBP14 localizes to the
same subcellular compartment as HSP47, an ER-resident
collagen-binding glycoprotein, confirming previous
reports that FKBP14 localizes to the ER.32 In contrast,
FKBP14 was undetectable in fibroblasts of affected individ-
uals whereas HSP47 showed a normal fluorescence pattern.10, 2012
Figure 5. Immunofluorescence of Extracellular
Matrix Proteins in Cultured Skin Fibroblasts
from Individuals with FKBP14 Deficiency
Disarray of collagen types I, III, VI, fibronectin, te-
nascins, thrombospondin, and the integrin
receptors a2b1 and a5b1 is demonstrated in
FKBP14-deficient fibroblasts of P1 and P3 in
comparison to control fibroblasts (one of two
control cultures is shown; the scale bars represent
10 mm). In control cells, collagen type I was
synthesized and mainly detected in the cyto-
plasm and only a few fibrils were assembled in
the extracellular compartment. In FKBP14-defi-
cient cells, collagen type I was reduced or not
detectable in the cytoplasm and absent in the
ECM. Collagen types III, V, and VI, fibronectin,
and tenascins were assembled by control fibro-
blasts in distinct extracellular networks whereas
FKBP14-deficient cells organized an extracellular
network only for collagen type V and did not
assemble a network for collagen type III and te-
nascins. The extracellular networks for collagen
type VI and fibronectin were almost completely
disorganized in FKBP14-deficient cells. In control
cells, thrombospondin was detected either in the
extracellular space or in the cytoplasm in the peri-
nuclear ER; in contrast, FKBP14-deficient cells did
not organize the protein in an extracellular
network and only a few intracellular deposits
were detected. The main receptors for collagens
and fibronectin, a2b1 and a5b1 integrins, were
not detectable in FKBP14-deficient cells.Absence of FKBP14 in fibroblasts of affected individuals
was also confirmed by western blot analysis (Figure 4A).
To determine whether the transcript harboring the
c.362dup mutation undergoes nonsense-mediated RNA
decay, FKBP14 transcripts were quantified by qRT-PCR on
mRNA extracted from fibroblast cultures of individuals
P1 and P3 (both homozygous for c.362dup) in comparison
to control fibroblasts. The relative expression ratio of
FKBP14 in fibroblasts homozygous for the mutation was
significantly reduced (4.7% 5 0.93% in P1 and 3.9% 5
0.73% in P3 [mean 5 SD], respectively; Figure 4C), indi-
cating that mutated mRNA is targeted for degradation via
nonsense-mediated decay.The American Journal of HumFKBP14 Deficiency Leads to Enlarged
ER Cisterns In Vivo and Disarray of the
Extracellular Matrix In Vitro
To examine the effects of FKBP14 deficiency
on collagen biosynthesis and secretion,
biochemical analyses of collagens from
cultured skin fibroblasts of P1 and P3 were
performed. The analyses showed normal
proportions and electrophoretic mobility
of the a chains of collagen types I, III, and
V (Figure S1, Supplemental Data).
In addition, transmission electron
microscopy was performed on a skin biopsy
sample of P1. The collagen fibrils showed
normal contours and diameters; however,the dermal fibroblasts presented with marked enlargement
of ER cisterns, which were filled with a flocculent material
(Figures 3H and 3I).
In order to understand the pathophysiological conse-
quences of FKBP14 deficiency, the organization of the
main components of the extracellular matrix (ECM), i.e.,
collagen types I, III, V, and VI, fibronectin, tenascins,
thrombospondin, and the main receptors of collagens
and fibronectin, a2b1 and a5b1 integrins was investi-
gated by indirect immunofluorescence microscopy on
cultured skin fibroblasts of individuals P1 and P3 and
two controls (Figure 5). Cultured skin fibroblasts of P1
and P3 showed generalized disarray for the majority ofan Genetics 90, 201–216, February 10, 2012 211
Table 3. Differential Diagnosis Based on Clinical Characteristics
Disease
FKBP14-
Deficient
EDS
LH1-
Deficient
EDS (VIA)
D4ST1-
Deficient
EDS (VIB)
Collagen
VI-Related
Ullrich CMD
Skin
Hyperelastic skin þ þ þ –
Follicular
hyperkeratosis
þ (þ) – þ
Striae distensae – – – (þ)
Easy bruising þ þ þ –
Fragile skin (þ) þ þ (þ)
Hypertrophic scars * (þ) – þ
Atrophic scars – þ þ þ
Joints/skeleton
Joint hypermobility þ þ þ þ
Joint dislocations (þ) þ þ (þ)
Joint contractures – – þ þ
Clubfoot deformities (þ) (þ) þ (þ)
Progressive
kyphoscoliosis
þ þ (þ) þ
Neuromuscular
Muscle hypotonia
at birth
þ þ (þ) þ
Delayed motor
development
þ þ þ þ
Weakness þ þ þ þþ
Respiratory
muscle failure
– – – þ
Vascular
Rupture of
large arteries
* x – –
Eyes
Bluish sclerae * (þ) þ (þ)
Microcornea – (þ) (þ) –
Retinal detachment – (þ) (þ) –
Rupture of eye globe – x – –
Ears
Hearing impairment þ – (þ) –
Stature
Marfanoid habitus – þ þ –
Miscellaneous
Herniae, diverticulae þ (þ) (þ) –
Cleft palate/cleft
soft palate
(þ) – (þ) –
Inheritance AR AR AR AD/AR
The following symbols and abbreviations are used: þ, present; (þ), occasion-
ally present; x, less common but characteristic if present; –, absent; þþ,
progressive weakness; *, yet uncertain criterion in this entity; AR, autosomal-
recessive; AD, autosomal-dominant.
212 The American Journal of Human Genetics 90, 201–216, Februarythe above-mentioned proteins. In comparison to control
cells, distinct extracellular networks for collagen types I
and III, tenascin, and thrombospondin were missing in
FKBP14-deficient cells and those for fibronectin and type
VI collagen were reduced and misassembled, the only
exception being type V collagen, which was organized in
an extracellular network that was similar to control fibro-
blasts. The main receptors for collagens and fibronectin,
a2b1 and a5b1 integrins, were not detectable in FKBP14-
deficient cells.Discussion
We describe an autosomal-recessive connective tissue
disorder caused by mutations in FKBP14. Clinically,
FKBP14-deficient EDS is characterized by the following
features: (1) severe generalized hypotonia at birth with
marked muscle weakness that improve in infancy; (2)
early-onset progressive (kypho)scoliosis; (3) joint hypermo-
bilitywithout contractures; (4) hyperelastic skinwith follic-
ularhyperkeratosis, easy bruising, andoccasional abnormal
scarring; (5) myopathy as confirmed by muscle MRI,
histology, and electron microscopy; (6) hearing impair-
ment, which is predominantly sensorineural; and (7)
a normal ratio of lysyl pyridinoline to hydroxylysyl pyridi-
noline (LP/HP) in urine. Occasional features that underline
systemic connective tissue involvement are aortic rupture
(in P*, the probably affected sister of P2), subdural hygroma
(potentially resulting from subdural bleeding or sponta-
neous intracranial hypotension),33 insufficiency of cardiac
valves, bluish sclerae, bladder diverticula, inguinal or
umbilical herniae, and premature rupture of membranes.
The course of the disease is characterized by delayed
motor development with gradual improvement of hypo-
tonia and muscle weakness during childhood. Ages of
unassisted walk ranged from 2.5 years to 4 years. All
affected individuals of the present study have reduced
muscle strength and report difficulties in walking long
distances and easy fatigability. Primary muscle disease
was confirmed on muscle biopsies, which showed mild
to moderate histological abnormalities by light micros-
copy and focal myofibrillar rearrangements and Z line
anomalies by electronmicroscopy, albeit without a specific
recognizable pattern. In addition, muscle MRI indicated
fatty degeneration of muscle tissue, an observation that
is typically found in myopathies and muscular dystro-
phies.34,35 Whether the decline in motor function that
started in the only adult person of the present study in
her forties is a consistent feature in the natural course of
FKBP14-deficient EDS remains to be clarified.
This disorder shares many clinical features with EDS
VIA and D4ST1-deficient EDS (EDS VIB) on the one hand
and the collagen VI-related congenital myopathies Ullrich
congenital muscular dystrophy (UCMD) and Bethlem
myopathy on the other hand; however, there are also clear
differences (Table 3).10, 2012
Individuals with UCMD as well as those with FKBP14-
deficient EDS present with generalized hypotonia, muscle
weakness, and joint hypermobility at birth. In addition,
both disorders show signs of myopathy and most individ-
uals with UCMD also develop (kypho)scolisis.13,36 But in
contrast to UCMD, FKBP14-deficient EDS does not seem
to be associated with progressive contractures of large
joints in particular hips, knees, and elbows13,36 whereas
skin hyperextensibility, one of the cardinal features of
FKBP14-deficient EDS, is not found in UCMD. A clear
difference is also observed in the natural course of both
disorders. In contrast to UCMD,motor function in individ-
uals with FKPB14 deficiency improves during childhood
and there is no marked decline in respiratory function.
Features that are common to EDS VIA, D4ST1-deficient
EDS, and FKBP14-deficient EDS are severe hypotonia at
birth with delayed motor development, joint hypermo-
bility, progressive (kypho)scoliosis, and hyperelastic skin
that bruises easily. High-frequency sensorineural hearing
loss was found in five of six of the individuals with
FKBP14-deficient EDS and has also been reported in
D4ST1-deficient EDS.17,19,37 Talipes deformities, one of
the hallmarks in D4ST1-deficient EDS,19 may occasionally
also occur in FKBP14-deficient EDS. However, congenital
contractures, particularly adduction-flexion contractures
of thumbs, which constitute another cardinal feature of
D4ST1-deficient EDS, as well as facial dysmorphisms,
arachnodactyly, and wrinkled skin over the palms and
fingers were not found in our cohort of individuals with
FKBP14-deficient EDS.
The most significant clinical overlap exists between
FKBP14-deficient EDS and EDS VIA. In addition to the
above-mentioned similarities, clinical features that are
common to both disorders are the potential risk for cata-
strophic vascular incidents and premature rupture of
membranes. However, FKBP14-deficient EDS differs from
EDS VIA first by the hearing impairment, which developed
in most individuals of the present study during early child-
hood (and which to the best of our knowledge has not
been reported so far in EDS VIA) and second by the absence
of an abnormal LP/HP ratio in urine, which is diagnostic
for EDS VIA. A third crucial point is muscle involvement
in individuals with FKBP14-deficient EDS in comparison
to EDS VIA. So far, studies focusing on the natural course
of muscle function in EDS VIA are scarce. In one recently
reported individual with EDS VIA, muscle biopsy in early
infancy was unremarkable but a follow-up study at the
age of 16 years showed myopathic changes and polyneur-
opathy.8 In a current study Rohrbach et al.38 comment on
the ability to walk of 15 newly diagnosed individuals with
EDS VIA, and point out that one of them (aged 16 years)
had severe scoliosis, hip dysplasia, and intellectual
disability and never learned to walk. It remains open
whether some degree of myopathy contributed to the
inability to walk in this person.
Considering the relatively small number of affected
individuals with FKBP14-deficient EDS in the presentThe Americastudy and the limited data on muscle involvement in
EDS VIA, it is too early to claim that the myopathic
aspect in FKBP14-deficient EDS is more pronounced
than in EDS VIA. Therefore the most important distinc-
tive features of this disorder in comparison to EDS VIA
are sensorineural hearing impairment and a normal
urinary LP/HP ratio. Because hearing impairment may
not manifest in the first months of life, the only reliable
distinctive criterion in the neonatal period is normal pyr-
idinoline excretion.
FKBP14 encodes for a 22 kDa protein that belongs to the
FK506-binding protein (FKBP)-family of peptidyl-prolyl
cis-trans isomerases (PPIases). cis-trans isomerization in
peptidyl-prolyl bonds is considered to be a rate-limiting
step in protein folding, and especially in folding of procol-
lagens because of their abundance of prolyl-residues.39–42
This process is accelerated by PPIases, which act as folding
catalysts and sometimes also have chaperone function.43
So far, available information on the function of FKBP14
has been scarce. According to electronic annotation,
FKBP14 is predicted to have a PPIase FKBP-type domain
and to carry two EF-hand motifs and an ER-retention
signal (UniProtKB/SwissProt).44 In fact, ER localization of
FKBP14 has been demonstrated by Raykhel et al.32 and
was also confirmed by our experiments in human control
fibroblasts (Figure 4B). The mutations in FKBP14 found
in the present study lead to FKBP14 deficiency in the ER.
Electron microscopy of a skin biopsy of P1 showed normal
shape and diameter of the collagen fibrils, and biochemical
analysis of collagens showed normal distribution and
electrophoretic migration of the a chains of collagen types
I, III, and V, respectively (Figure S1, Supplemental Data).
Moreover, the relative amount of collagen types I, III,
and V in the medium and the cell layers of FKBP14-defi-
cient fibroblasts was comparable to that of the controls.
However, on electron microscopy the ER cisterns of skin
fibroblasts were dilated and filled with flocculent material.
An influence of FKBP14 on extracellular matrix compo-
nents is suggested by immunofluorescence experiments
on FKBP14-deficient skin fibroblasts, which showed dis-
turbed distribution and assembly of several ECM compo-
nents. In particular, a disarray of the extracellular network
of collagens type I and type III and fibronectin as well as
their receptors was observed. This is a common trait of
in-vitro-cultured fibroblasts derived from individuals
with different types of EDS, irrespective of the gene
mutated.29,30 Indeed, mutations in the genes for collagen
types I, III, and V as well as PLOD1, which is involved in
the maturation of collagen molecules, affect the assembly
of various components of the ECM in EDS skin fibroblasts.
Matrix assembly is considered to be a step-wise process
that is usually initiated by ECM glycoproteins binding to
cell surface receptors such as fibronectin dimers binding
to integrin receptors. Once assembled, the fibronectin
matrix contributes to the assembly of other ECM compo-
nents.45 Hence, impaired assembly of one ECM compo-
nent may entail disturbed assembly of others. Based onn Journal of Human Genetics 90, 201–216, February 10, 2012 213
these considerations, FKBP14 might act on one or several
components of the ECM.
FKBP10 (MIM 607063), another ER-resident member of
the FKBP family of PPIases, has recently been shown to
interact with the collagen triple helix and to act as a
chaperone.43 Loss-of-function mutations in FKBP10
affect secretion of type I collagen and lead to an osteogene-
sis imperfecta and Bruck syndrome phenotype (MIM
610968).46–48 It is tempting to speculate that FKBP14might
also act as a folding catalyst or chaperone for one or more
components of the extracellular matrix and that ER stress
in response to the accumulation of misfolded proteins
might play a role in the pathophysiology of FKBP14-
deficient EDS. Biochemical analysis in FKBP14-deficient
cells showed normal proportions and electrophoretic
mobility of the a chains of collagen types I, III, and V.
However, altered secretion of other extracellular matrix
components such as fibronectin, collagen type VI, and in-
tegrin subunits cannot be excluded. More functional data
are needed to unravel the exact pathogenetic mechanisms
of FKBP14 deficiency.
Remarkably, a 1 base pair insertion of a cytosine residue
within a 5C-nucleotide stretch in exon 3 was found in all
affected individuals on at least one allele. Analysis of
flanking SNPmarkers showed that the 1 base pair insertion
is linked to the same haplotype in all mutation carriers.
Despite the geographically diverse origin of the individuals
involved in this study, it is possible that this mutation
traces back to the same founder event. However, a recurrent
mutation resulting from replication slippage in the polycy-
tidine tract cannot be excluded.
In conclusion, we report an autosomal-recessive variant
of EDS caused by mutations in FKBP14. The wide spectrum
of clinical features in this condition may be due to a dis-
turbance of protein folding in the ER affecting one or
more components of the extracellular matrix in various
body parts and organs such as joints, ligaments, skin,
vessels, ear, eye, and muscle. FKBP14 mutation analysis
should be considered in all individuals with apparent
kyphoscoliotic type of EDS and normal pyridinoline excre-
tion, in particular in conjunction with sensorineural
hearing impairment.Supplemental Data
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